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Título: Salud mental en personas con trastorno por consumo de sustan-
cias: aspectos diferenciales entre hombres y mujeres 
Resumen: El propósito de este estudio es presentar el perfil psicopatoló-
gico y las diferencias entre hombres y mujeres que inician tratamiento resi-
dencial para las adicciones. 
La muestra se compuso de 142 pacientes (116 hombres y 26 mujeres), que 
cumplimentaron el EuropASI y MMCMI-III.  
Se analizan variables socio-demográficas, patrón de consumo y otras carac-
terísticas, así como patrones, trastornos de personalidad y síndromes clíni-
cos. El grupo de hombres presenta alta prevalencia en el patrón de perso-
nalidad antisocial (31%). Las mujeres, en el depresivo (23.1%), dependiente 
(26.9%) y antisocial (26.9%), solo en el dependiente las diferencias son es-
tadísticamente significativas. 
En los síndromes clínicos los hombres presentan prevalencia en dependen-
cia de sustancias (86.2%), trastorno de ansiedad (60.3%) y dependencia de 
alcohol (45.7%), las mujeres en el trastorno de ansiedad (76.9%), depen-
dencia de alcohol (69.2%), sustancias (53.8%) y distímico (46.2%). Apare-
cen diferencias significativas estadísticamente en el trastorno ansioso, dis-
tímico y dependencia de alcohol, donde las mujeres se muestran más afec-
tadas. 
En el síndrome clínico trastorno de pensamiento los hombres puntúan 
más alto y las mujeres más altas en depresión, en ambos casos las diferen-
cias son estadísticamente significativas. 
Se comentan las implicaciones que estos resultados tienen en la evaluación 
y mejora de los tratamientos.  
Palabras clave: Patología dual; Trastornos de personalidad; Adicciones; 
Psicopatología; Género. 
  Abstract: The aim of this study is to present the psychopathological pro-
file and differences between men and women who begin additional resi-
dential treatment for addiction. 
The sample included 142 patients (116 men and 26 women). We analysed 
socio-demographic variables, substance use pattern as well as personality 
disorders and clinical syndromes using EuropASI and MCMI-III as evalu-
ating instruments.  
The male group showed a high prevalence of antisocial personality disor-
der (31%). However, women did so in depressive (23.1%), dependent 
(26.9%) and antisocial (26.9%) patterns, finding statistically significant dif-
ferences only for dependent disorder.  
For clinical syndromes, men showed relevant prevalence substance de-
pendence was analysed (86.2%), anxiety disorder (60.3%) alcohol depend-
ence (45.7%), while the women´s group showed prevalence for anxiety 
disorder (76.9%), alcohol dependence (69.2%), substances (53.8%) and 
dysthymic (46.2%). We found statistically significant differences in anxiety 
disorder, dysthymic and alcohol dependence where women appeared more 
affected.  
Men showed higher scores for thought disorder, and women for depres-
sion, both differences being statistically significant. 
Results are discussed and their clinical implications analyzed. 





Addiction is a multifaceted problem and affects every aspect 
of the lives of those who develop it (López Durán et al., 
2008; Carrol and Rounsaville, 2002), the population with 
substance use disorder is one of the most difficult in terms 
of clinical management (Pedrero, 2003). One factor explain-
ing part of this difficulty is high psychopathological comor-
bidity. Attending to the individual characteristics of users is 
vital for an effective treatment approach to addictive condi-
tions, or, as the National Institute on Drug Abuse (2010) 
states, “no single treatment is appropriate for every-
one…effective treatment attends to multiple needs of the 
individual, not just his or her drug use”. 
Improving the success rates of intervention programs has 
brought interest in the study of variables that limit or medi-
ate the scope and effectiveness of these programs, with Per-
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sonality Disorder (PD) the most common comorbid diagno-
sis in people with addiction. (Becoña and Cortés, 2008). Part 
of the problem of substance use is due to dysfunctional be-
havior patterns maintained over time with high stability 
which determine the persistence of addictive behavior and 
the failure of strategies aimed at their control (Larson, Desai, 
y Kates, 2018; Pedrero, Puerta, Lagares and Sáez, 2003). 
We wish to stress the importance of studies relating to 
personality patterns with addictive behavior and other psy-
chopathological conditions (Coriale et al, 2019; Karpyak et 
al, 2019). Some studies affirm that these patterns greatly in-
fluence diagnosis, therapeutic intervention and prognosis. 
Martínez & Trujillo (2003) highlight some consequences of 
personality disorders on a dual diagnosis drug dependent 
population if there is no proper approach to the comorbid 
disorder: difficulty in achieving abstinence with frequent re-
lapse, less adherence and retention to treatment, misuse and 
abuse of psychopharmaceuticals, and deterioration of the pa-
tient-therapist relationship among others. 
The relationship between personality disorders and sub-
stance use is complex, given there is great variability for 
prevalence rates, which depend both on substance and 
444                                                                Asunción Santos-de Pascual et al. 
anales de psicología / annals of psychology, 2020, vol. 36, nº 3 (october) 
methodology used (criteria, questionnaires, cut-off points ...). 
Difficulties in establishing prevalence rates are based on both 
conceptual and methodological aspects, therefore, preva-
lence of personality disorders in cocaine-dependent subjects 
ranges from 36.7% (Lorea, Fernández-Montalvo, López-
Goñi and Landa, 2008) and 97% (Calsyn and Saxon, 1990). 
The prevalence of PD ranges in the normal population is be-
tween 10% and 15% (Verheul, 2001). 
It should also be noted that the prevalence of personality 
disorders found in drug dependent populations in treatment 
is questionable, since evaluation of these disorders is often 
carried out at the onset of treatment. Behaviors derived from 
the addiction itself often overlap with the descriptions of 
particular personality disorders (Rodriguez and Salgado, 
2018). 
Skinstad & Swain (2001), and San-Molina (2004) con-
cluded that the most frequent personality disorders in the 
substance use population are firstly those belonging to clus-
ter B, specifically borderline personality disorder (BPD) and 
antisocial personality disorder (ASPD). Followed by cluster 
C disorders such as avoidant personality disorder (APD), 
passive-aggressive personality disorder (PAPD), obsessive-
compulsive personality disorder (OCPD); and lastly cluster A 
disorders, highlighting Schizoid personality disorder (SPD). 
Bravo De Medina, Echeburúa, & Aizpiri (2007), found the 
most prevalent personality disorders in an alcoholic popula-
tion, those matching histrionic (63.6%), narcissistic (67.4%), 
and antisocial (67.5%) personality patterns, all from Cluster 
B. Similar results were found by López & Becoña (2006) in a 
cocaine dependent population, passive-aggressive (33.3%), 
antisocial (22.5%), and narcissistic (18.6%) personality pat-
terns were most prevalent. Similarly, results from Fernández-
Montalvo, López-Goñi, & Landa (2004), in a therapeutic 
community population showed greater prevalence of ASPD 
(42.9, followed by PAPD and narcissistic personality disor-
der (21.4%). 
Although in recent years several studies have explored 
gender differences in substance dependence treatment, re-
sults are far from conclusive (Fernandez-Montalvo, López-
Goñi, Azanza, and Cacho, 2014). The paucity of research 
addressing gender differences may be mediated by the diffi-
culty of obtaining sufficiently large samples of women with 
drug use problems which allows incidence and features of 
drug dependence in women to be studied with a minimum 
of representativeness (Castillo, Llopis, Rebollida, Fernández 
yOrengo, 2003). In the scientific literature, it is found that 
most studies analyze the mixed population which propor-
tionally is not generally above 20% of female users. López-
Goñi, Fernández-Montalvo, and Arteaga, (2012) for instance, 
obtained a profile of 80.5% men, Roncero et al., (2016) a 
profile with 84% men, and data from users attended by 
UNAD (2018) estimate only 25% of care for women (includ-
ing advisory services to families, employment, specific to 
women ...), while Proyecto Hombre nationwide has attended 
to a proportion of women at 16.6% (Proyecto Hombre As-
sociation 2018). This low number of female users attending 
treatment centers may be explained by the lower proportion 
of addicted women, or because women suffer greater social 
stigma, hindering their search for therapeutic assistance, nei-
ther possibility being exclusive (Fernández- Montalvo et al., 
2014). 
The Spanish National Strategy on Addictions focuses on 
the fact that women can suffer twice over: firstly, as victims 
of gender violence by a partner also a drug user and women 
themselves may also have a substance related disorder due to 
this violence (National Strategy on Addictions 2017-2024). 
Studies indicate female drug users generally present more 
anxiety and depressive symptoms and more problems adapt-
ing to daily life than men, using alcohol later in life than men, 
being significantly older when this pattern becomes prob-
lematic. They also report more problems related to family, 
social life, and mental and physical health, while men report 
higher criminality rates and thus legal and financial problems 
(Ávila and González, 2007; Fernandez-Montalvo et al., 2014; 
Storbjörk, 2011) 
As regards personality disorders, Miquel, Roncero, 
López-Ortíz and Casas (2011) following a systematic review 
of 40 published studies with information on gender differ-
ences in prevalence and clinical characteristics in dual diag-
nosed patients, reported a greater prevalence of psychotic 
and bipolar disorders in men, while in women a higher prev-
alence of anxiety and affective disorders, more daily life im-
pairment, related to a higher prevalence of OCPD, depend-
ent, and histrionic personality patterns.  
Therefore, there appears to be a clearly defined gender 
profile. The higher presence of anxious depressive sympto-
matology and cluster C personality disorders lies in female 
drug users. 
The aim of this work is to identify the socio-
demographic and psychopathological features of users with 
an addiction problem, and differences amongst men and 






We performed a non-experimental cross-sectional de-
scriptive study with two independent groups paired by gen-
der (male, female). 
This protocol has been designed following the principles 
in the Helsinki Declaration, and with the approval of Solidar-
idad y Reinserción Foundation (Proyecto Hombre Murcia). 
All participants provided written informed consent for inclu-




The sample consisted of people, who voluntarily request-
ed treatment for addiction from the Solidarity and Reinser-
tion Foundation in the residential treatment program from 
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January 2013 to December 2016. This program caters for pa-
tients throughout the region with addiction problems. 
Participants were 142 drug users 81.69% (n = 116) male 
and 18.31% (n = 26) female, aged between 18 and 62 (M = 
38.99 years; SD = 9.203), mostly single (55.71%), followed 
by 24.29% divorced and 20% married. 67.18% of the sample 
had no formal education, while 8.4% had completed basic 
education, 18.325 intermediate, and 6.11% university. 
Cocaine motivated most treatment requests (37.7%). The 
mean age of first substance use was 20.41 years old (SD = 
8.094). Patients had been consuming on average 14.11 years 




The evaluation instruments used are part of the center´s 
clinical evaluation protocol; and not specifically selected for 
this study. 
The EuropASI (Kokkevi and Hartgers, 1995) is the Eu-
ropean version of the Addiction Severity Index (ASI), 
(McLellan, Luborsky, Woody, and O'Brien, 1980), we used 
the Spanish version by Bobes, González, Saiz, and Bousoño 
for this study (1996). This is a semi-structured, hetero-
applied clinical interview with a total of 159 items, widely 
used for evaluation and diagnosis of patients on admission to 
treatment programs. It explores six areas of special relevance 
to addiction problems: physical health, employment and re-
sources, alcohol and / or drug use, legal situation, family his-
tory, family and social relationships, and mental health. Be-
sides different items for each area, the instrument also re-
turns a severity index for each. Scores range from 0 (no 
problem) to 9 (extreme problem). Taking into account that 
from 4 it is already considered that treatment may be indi-
cated.  
The Millon Multiaxial Clinical Inventory (MCMI III), 
(Millon, Davis and Millon, 2007), is a self-applied clinical 
questionnaire of 175 dichotomous response items (true / 
false). It is used both in clinical practice and research in the 
field of addiction (Perea-Baena, Compán and Ortíz-Tallo, 
2009; Pérez, Durán and del Río, 2012; Pedrero, 2003; López-
Goñi, Fernández-Montalvo and Arteaga, 2015; Arteaga, Fer-
nández ‐ Montalvo and López ‐ Goñi, 2015; etc.). As well as 
four modifying indices (sincerity, social desirability, devalua-
tion and validity), it presents 24 scales divided into four 
blocks according to severity level : eleven clinical personality 
patterns defined in Axis II of the DSMIV-TR (American 
Psychiatric Association, 2000), three serious pathological 
personality patterns of seven clinical syndromes of moderate 




All participants were interviewed by psychology profes-
sionals with experience in the area of addiction; this evalua-
tion was performed in three sessions before starting treat-
ment. In the first session, data related to sociodemographic 
conditions and drug use was collected throug h EuropASI, 
and the remaining protocol questionnaires were applied in 
the following sessions. 
Inclusion criteria: a) meet criteria for diagnosis of sub-
stance dependence disorder according to DSM-IV-TR 
(American Psychiatric Association, 2000), b) be aged be-
tween 18 and 65 c) consume any addictive substance, with or 
without other associated addictive behaviors, with serious 
impairment in personal, social, family and work functioning, 





Descriptive analyzes were performed for all variables cal-
culating frequency and percentage distribution, as well as cal-
culations of mean and standard deviations. We used Pear-
son’s Chi-Square and Fisher’s exact test to measure and 
compare significant differences between male and female 
participants based on distribution of prevalence of variables. 
For continuous variables, both parametric (Student T) and 
non-parametric tests (U Mann of Whithney) were used, de-
pending on whether these variables fit the normal distribu-
tion (K-S Kolmogórov-Smirnov). Differences were consid-
ered statistically significant when p < .05. To calculate the ef-
fect size of nonparametric tests, we calculated r (r = Z / √N) 
in accordance with the procedure described by Rosenthal 
(1991) for nonparametric tests, and G Heghes for t tests with 
non-equivalent groups. All statistical data was performed us-




The mean age of men (Table 1) accessing treatment (38.44 
years / SD = 8.913) is lower than women (41.46 years / SD 
= 10.222) (t (26.06) = -2.11, p < .05). Although percentage of 
married people is the same for both sexes, the percentage of 
divorced or widowed is significantly higher (40% women to 
20.87% men). There are no statistically significant differ-
ences between gender and level of studies, as most users had 
no educational qualification (67.18%). 
For male participants cocaine is the primary used sub-
stance motivating treatment (37.9%), and alcohol for female 
participants (42.3%). However, the mean age of first sub-
stance use in men is 19.45 years old (SD = 6.943), an average 
of 14.11 years (SD = 8.943) of substance use before entering 
treatment. As for women, mean age of first drug substance 
use is noticeably higher (M = 24.57 years; SD = 11.139), en-
tering treatment after a mean of 11.39 years (SD = 8.349), 
with no significant differences found. 
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Table 1. Comparison of sociodemographic and clinical variables. 
 Total (n = 142) Male (n = 116) Female (n = 26)   
 Mean (SD) Mean (SD) Mean (SD) T (fd) p 
Age 38.99 (9.203) 38.44 (8.913) 41.46 (10.222) -2.11 (26.06) .045* 
Substance use time 14.11 (8.943) 14.74 (8.998) 11.39 (8.349) 1.627 (121) .106 
Age of first substance use 20.41 (8.094) 19.45 (6.943) 24.57 (11.139) -1.520 (140) .131 
 % % % X2(gl) p 
Marital Status    4.444 (2) 0.108 
Married 20 20 20   
Single 55.71 59.13 40   
Divorced/widowed 24.29 20.87 40   
Educational Qualifications    - - 
No Qualification. 67.18 69.81 56   
Basic Q. 8.4 7.55 12   
Intermediate Q.  18.32 18.87 16   
College Q. 6.11 3.77 16   
Previous Income 18.4 19 16 0.120 (1) 1 
Substance     8.636(2) .013* 
Alcohol 21.8 17.2 42.3   
Cocaine 37.7 37.9 34.6   
Others 40.8 44.8 23.1   
*p < .05; **p < .01; *** p < .001 
 
Regarding symptomatology prevalence (Table 2), accord-
ing to results obtained through the MCMI-III questionnaire, 
we found 79% of prevalence of mild symptomatology 
(PREV > 74), suggesting the presence of personality disor-
ders (80.8% women and 66.4% men). By applying stricter 
criteria (PREV > 84) the rate of personality disorders would 
be 31.7% (34.6% for women and 31% for men) (see Table 
2). 
As for prevalence of personality disorders, when we 
crossed the variable with gender, significant differences were 
only found for the dependent pattern (χ² = 16.378 (1) p < 
.001), much higher in women (26.9%) than men (3.4%). Sim-
ilar to the depressive pattern (23.1% women, 10.3% men), 
compulsive (11.5% women, 3.4% men), avoidant (11.5% 
women, 6% men) and self-destructive (7.7% women, 2.6% 
men), these differences not being statistically significant. 
Nevertheless, although also without significant differences, a 
higher prevalence was found for schizoid personality disor-
ders in men (5.2% men, 0% women), narcissistic (9.5% men, 
0% women) and antisocial (31% men, 26.9% women). 
 Women show higher prevalence for clinical syndromes 
and differences are statistically significant in somatoform 
(15.4% women, 0.9% men), bipolar (30.8% men, 21.6% 
women), dysthymic (46.2% women, 14.7% men), post-
traumatic stress (11.5% women, 1.7% men) and major de-
pression (26.9% women, 10.9% men). Men present more 
prevalence in thought disorder (42.2% men, 7.7% women) 
and substance dependence (86.2% men, 53.8% women). 
 
Table 2. Prev MCMI-III. 
 Prev > 74 < 85 Prev > 85 Prev > 74 (Total) 
χ² (fd) 
 
 Male Female Male Female Male Female Total  
 n (%) n (%) n (%) n (%) n (%) n (%) n (%)  
Clinical Personality patterns    
Schizoid 5 (4) 0 (0) 1 (0.9) 0 (0) 6 (5.2) 0 (0) 6 (4.2) 1.404 (1) 0.592  
Avoidant 7 (6) 3 (11.5) 0 (0) 0 (0) 7 (6 ) 3 (11.5) 10 (7) 0.983 (1) 0.391  
Depressive 9 (7.8) 4 (15.4) 3 (2.6) 2 (7.7) 12 (10.3) 6 (23.1) 18 (12.7) 3.110 (1) 0.101  
Dependant 1 (0.9) 3 (11.5) 3 (2.6) 4 (15.4) 4 (3.4) 7 (26.9) 11 (7.7) 16.378 (1) 0.001***  
Histrionic 2 (1.7) 1 (3.8) 3 (2.6) 0 (0) 5 (4.3) 1 (3.8) 6 (4.2) 0.011 (1) 1  
Narcissistic 6 (5.2) 0 (0) 5 (4.3) 0 (0) 11 (9.5) 0 (0) 11 (7.7) 2.673 (1) .216  
Antisocial 23 (19.8) 3 (11.5) 13 (11.2) 4 (15.4) 36 (31) 7 (26.9) 43 (30.3) 0.170(1) .680  
Agressive (sadistic) 0 (0) 1 (3.8 ) 5 (4.3) 1 (3.8) 5 (4.3) 2 (7.7) 7 (4.9) 0.518 (1) .612  
Compulsive 3 (2.6) 3 (11.5) 1 (0.9) 0 (0) 4 (3.4) 3 (11.5) 7 (4.9) 2.966 (1) .115  
Negativistic (passive-aggresive) 4 (3.4) 0 (0) 4 (3.4) 1 (3.8) 8 (6.9) 1 (3.8) 9 (6.3) 0.333(1) 1  
Self-destructive 0 (0) 2 (7.7) 3 (2.6) 0 (0) 3 (2.6) 2 (7.7) 5 (3.5) 1.630 (1) .227  
Severe personality pathology    
Schizotypal 1 (0.9) 0 (0) 1 (0.9) 1 (3.8) 2 (1.7) 1 (3.8) 3 (2.1) 0.462(1) .457  
Borderline 4 (3.4) 0 (0) 1 (0.9) 2 (7.7) 5 (4.3) 2 (7.7) 7 (4.9) 0.518(1) .612  
Paranoid 10 (8.6) 1 (3.8) 2 (1.7) 2 (7.7) 12 (10.3) 3 (11.5) 15 (10.6) 0.032(1) 1  
Clinical syndromes    
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 Prev > 74 < 85 Prev > 85 Prev > 74 (Total) 
χ² (fd) 
 
 Male Female Male Female Male Female Total  
 n (%) n (%) n (%) n (%) n (%) n (%) n (%)  
Anxiety D. 30 (25.9) 2 (7.7) 40 (34.5) 18 (69.2) 70 (60.3) 20 (76.9) 90 (63.4) 2.515(1).113  
Somatoform D. 1 (0.9) 3 (11.5) 0 (0) 1 (3.8) 1 (0.9) 4 (15. 4) 5 (3.5) 13.186(1) .004**  
Bipolar D. 16 (13.8) 5 (19.2) 9 (7.8) 3 (11.5) 25 (21.6) 8 (30.8) 33 (23.2) 1.012(1) .315  
Dysthymic D. 10 (8.6) 5 (19.2) 7 (6) 7 (26.9) 17 (14.7) 12 (46.2) 29 (20.4) 12.967(1) .000***  
Alcohol Dependence 29 (25) 4 (15.4) 24 (20.7) 14 (53.8 ) 53 (45.7) 18 (69.2) 71 (50) 4.708(1) .030*  
Substance Dependence 32 (27.6) 6 (23.1) 68 (58.6) 8 (30.8) 100 (86.2) 14 (53.8) 114 (80.3) 14.051(1) .000***  
PTSD 1 (0.9) 1 (3.8) 1 (0.9) 2 (7.7) 2 (1.7) 3 (11.5) 5 (3.5) 6.022(1) .043*  
Severe clinical syndromes    
Thought D. 28 (24.1) 0 (0) 21 (18.1) 2 (7.7) 49 (42.2) 2 (7.7) 51 (35.9) 11.015 (1) .001***  
Major D. 9 (7.8) 4 (15.4) 3 (2.6) 3 (11.5) 12 (10.3) 7 (26.9) 19 (13.4) 5.037(1) .049*  
Delusional D. 21 (18.1) 4 (15.4) 3 (2.6) 3 (11.5) 24 (20.7) 7 (26.9) 31 (21.8) 0.484(1) .487  
* p < .05; ** p < .01; *** p < .001   
 
When focusing on descriptive data (Table 3), highest 
scores are found in substance and alcohol dependency scales. 
In both cases, cut-off points established as criteria in the 
MCMI-III are exceeded, with women most serious in alcohol 
dependence (80.65 women, 74.53 men). Men present higher 
scores in substance dependence (87.34 men, 77.40 women). 
Among clinical syndromes, apart from substance de-
pendence (UMW 814.5, p < .001) and thought disorder 
(UMW 1058, p < .05) where men obtained higher scores, 
women presented greater symptomatology severity for re-
maining scales. Statistically significant differences were found 
for anxiety disorder (UMW 998 p < .05), somatoform disor-
der (UMW 965.5, p < .01) and dysthymic disorder (UMW 
921.5, p < .01). 
As for personality disorders, the antisocial pattern 
achieves higher scores for both sexes though higher in men 
(72.09 men, 68.46 women). There exist differences between 
sexes for two traits, women present higher scores for the de-
pendent pattern (UMW 957, p < .01), while men for the nar-
cissistic pattern (UMW 853.5, p < .001). 
 




fd Student’s t/ Mann Whitney’ U (p) Heghes’ G/ r 
 Male Female Total 
Clinical Personality patterns   
Schizoid (0-99) 51.52 (18.152) 54.19 (14.838) 52.02 (17.561) 137 t -.698 (.487) GH .02 
Avoidant (0-95) 52.25 (19.301) 54.65 (24.524) 52.70 (20.302) 137 t -.513 (.588) GH .01 
Depressive (0-81) 55.23 (19.888) 56.62 (23.444) 55.49 (20.515) 137 t -.309 (.757) GH .01 
Dependant (0-104) 53.54 (18.193) 62.04 (23.692) 55.13 (19.529) 137 MW U957 (.006)** r -.23 
Histrionic (0-85) 34.04 (20.167) 42.46 (23.658) 35.62 (21.032) 137 MWU 1118.5 (.058) r -.16 
Narcissistic (13-105) 59.17 (16.169) 44.04 (20.697) 56.34 (18.024) 137 MWU 853.5 (.001)*** r -.28 
Antisocial (17-106) 72.09 (12.248) 68.46 (13.480) 71.41 (12.517) 137 t 1.336 (.184) GH .03 
Agressive (sadistic) (0-102) 60.83 (13.432) 55.31 (15.115) 59.80 (13.874) 137 t 1.846 (0.67) GH .04 
Compulsive (0-93) 36.55 (17.011) 43.54 (22.066) 37.94 (18.175) 137 t -1.492 (.145) GH .04 
Negativistic (passive-aggresive) (0-69) 56.58 (16.816) 50.23 (20.789) 55.40 (17.719) 137 t 1.659 (.099) GH .04 
Self-destructive (0-67) 52.32 (14.535) 53.62 (13.206) 52.56 (14.259) 137 t -.417 (.677) GH .01 
Severe personality pathology   
Schizotypal (0-102) 49.92 (21.989) 50.00 (21.073) 49.93 (21.750) 137 t -.017 (.987) GH .23 
Borderline (0-80) 61.20 (13.241) 60.35 (17.933) 61.04 (14.166) 137 t .277 (.782) GH .38 
Paranoid (0-104) 57.50 (21.156) 60 (18.095) 57.96 (20.595) 137 t -.547 (.585) GH .03 
Clinical syndromes   
Anxiety D. (0-105) 71.81 (24.144) 79.58 (26.062) 73.28 (24.607) 137 MWU 998 (.013)* r -.21 
Somatoform D. (0-107) 41.18 (25.066) 52.46 (29.085) 43.29 (26.128) 137 MWU 965.5 (.006)** r -.23 
Bipolar D. (10-93) 62.63 (18.551) 66.96 (18.235) 63.44 (18.504) 137 t-1.077 (.283) GH .02 
Dysthymic D. (0-96) 55.58 (23.807) 69.50 (26.927) 58.18 (24.921) 137 MWU 921.5 (.003)** r -.25 
Alcohol Dependence (0-115) 74.53 (14.244) 80.65 (22.441) 75.68 (16.189) 137 MWU 1031.5 (.021)* r -.19 
Substance Dependence (54-110) 87.34 (13.590) 77.40 (16.803) 85.51 (14.684) 137 MWU 814.5 (.001)*** r -.28 
PTSD (0-104) 51.99 (20.355) 59.5 (24.046) 53.33 (21.187) 137 t -1.562 (.121) GH .22 
Severe clinical syndromes   
Thought D. (0-108) 61.79 (27.451) 54.23 (24.443) 60.37 (26.992) 137 MWU 1058 (.026)* r -.19 
Major D. (0-91) 48.63 (26.935) 56.15 (29.088) 50.04 (27.400) 137 t -1.265 (.208) GH .03 
Delusional D. (0-101) 61.13 (23.232) 61.31 (25.344) 61.17 (23.546) 137 t -.034 (.973) GH .001 
* p < .05; ** p < .01; *** p < .001 
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Discussion 
 
The aim of this paper is to learn the socio-demographic and 
psychopathological characteristics of addiction treatment pa-
tients in Murcia, and specific characteristics defined by gen-
der. 
As a result of this study, we found that the profile of a 
person entering treatment in PH Murcia is a man (81.89%), 
mean age 39 years, single (55.71%), and with no formal edu-
cation (86.18%), a cocaine user (37.7%) alcohol user (21.8%), 
began consuming at 20 years old, and is seeking treatment af-
ter 14 years of active substance use. 
This profile is similar to those provided by other associa-
tions working in the area in Spain in 2017 such as the Proy-
ecto Hombre Association (2018) with 2960 cases and UN-
AD (2018) with 44787 cases evaluated across the country. In 
the Spanish scientific literature these results have been stable 
in the last decade. López-Goñi, Fernández-Montalvo, & Ar-
teaga, (2012), obtained a profile of 80.5% men, aged 37.6 
years and 49.9% cocaine users. However, data obtained by 
López-Goñi, Fernández-Montalvo, Arteaga, & Esarte (2017) 
showed 73.5% of male participants with a mean age of 36.4, 
mainly cocaine user (39.3%), and Roncero et al. (2016) a pro-
file of 84% males, with a mean age of 38.9, cocaine users 
(36.9%). This profile already provided by the Spanish Na-
tional Plan on Addiction (2009-2016) reported higher co-
caine use than heroin. 
Other relevant data is the scarce percentage of women 
seeking addiction treatment (18.31%), in line with data from 
other studies in the Spanish population usually 11% to 25% 
of female participants (Fernández Del Río, López, & 
Becoña, 2011; García Rodríguez et al., 2005; Iraurgi Castillo, 
Sanz Vázquez, & Martínez, 2004; Pérez del Río, 2012; 
Rodriguez & Salgado, 2018; Roncero et al. 2016; UNAD 
2018; Proyecto Hombre Association, 2018). 
Another variable where we found statistically significant 
differences is the mean age when treatment begins (38.44 
years for men and 41.26 for women). There are notable dif-
ferences in years of drug use before starting treatment (14.74 
men / 11.39 women) and mean age of starting substance use 
(19.45 men / 24.57 women), although there is no statistical 
significance. These differences coincide with data provided 
by other studies; Ávila and González (2007), in a sample of 
370 patients with alcohol addiction, 325 men (87.8%) and 45 
women (12.2%), with a mean age of 42.83 and 44.60. respec-
tively, indicated that women begin drinking significantly later 
than men (19.61 and 16.90), were quite older when the 
drinking pattern became problematic (30.93 and 24.68 years), 
had fewer years of substance use (13.26 versus 17.85 years). 
This pattern is repeated in data provided by the UNAD ad-
diction report (2018), where percentage of users over 45 
years of age is higher in women (24% women, 22% men), a 
trend reversed in years of substance use before start of 
treatment, where percentage of men with over 11 years his-
tory of substance use is 40% while 32% for women. 
The main substance motivating treatment for each gen-
der group is different, for men cocaine 37.9% and women 
alcohol consumption 42.3%. These data coincide with scores 
obtained in MCMI-III where women had higher mean scores 
for alcohol dependence (80.65 women, 74.53 men) while 
men higher mean scores in severity scale in substance de-
pendence (87.34 men, 77.40 women). Blanco, Sirvent and 
Palacios (2005), affirm alcohol and tobacco use is substan-
tially higher in women. Men consume cocaine or cannabis to 
a greater degree, data contributed by the EDADES report 
(2017), UNAD (2018) or the Proyecto Hombre Association 
(2018), show that most women seek treatment for their alco-
hol and tobacco dependence and men tend to seek treatment 
for their cannabis and cocaine dependence.  
This study indicates that the presence of psychopatholo-
gy in the analyzed sample is quite high, 79% of participants 
present scores with clinical indicators of personality disor-
ders (80.8% women and 66.4% men). Although following 
the strictest criteria, 31.7% have at least one personality dis-
order (43.6% women and 31% men). 
 These results coincide with other studies such as 
Pedrero et al. (2003) and Fernández Montalvo et al. (2014) 
finding 83% and 76.2% of users with at least one personality 
disorder respectively. Craig (2000) obtained 91% prevalence 
of comorbid personality disorder in a sample of 160 opiate 
users and 283 cocaine users, using MCMI II. 
This study finds a greater presence of psychopathology 
associated with substance use in women than men, however 
no clear evidence whether dual pathology is more common 
in either sex. Research in mental health settings found great-
er rates of male patients with dual pathology than women, 
whereas in drug dependency treatment units data showed the 
opposite (Miquel et al, 2011). In Spain, a study carried out 
with a population from several drug dependency treatment 
units found 47.5% of women meet criteria for dual patholo-
gy, while 30.3% of men met the same criteria (Gual, 2007). 
Rodríguez-Jiménez et al (2008) instead conducted a study in 
a sample of 257 patients from a psychiatric hospitalization 
unit (UHPHG) in Madrid finding 24.2% of patients met cri-
teria for both substance dependence disorder and comorbid 
psychopathological disorder, 87.5% men and 12.5% women. 
As for personality disorders more concomitant with sub-
stance use, in this study, using the least strict criterion 
(PREV > 74), we have antisocial personality disorder, pre-
sented by 30.3%, paranoid (10.6%), narcissistic (7.7%) and 
dependent (7.7%). These data coincide with other studies, 
thus, Rodriguez and Salgado, (2018) found 42.5% of patients 
(N: 106) with some personality disorder, antisocial disorder 
being most prevalent (25.5%), paranoid (13.2%) and narcis-
sistic (11.3%). Fernández-Montalvo, López-Goñi and Landa 
(2004) found 42.86% of a sample of 42 patients who sought 
treatment diagnosed with antisocial personality disorder, fol-
lowed by passive-aggressive personality disorder (40.5 %) 
and narcissistic personality disorder (21.4%). Data similar to 
that by Skinstad and Swain (2001) and San-Molina (2004) 
mentioned in the introduction. As for differences between 
Mental health in people with substance use disorder: differential aspects between men and women                                                                  449 
 
anales de psicología / annals of psychology, 2020, vol. 36, nº 3 (october) 
men and women, the dependent pattern is highest in the 
former (26.9 % vs. 3.4% in men) coinciding with the findings 
of Pedrero et al. (2003) (47.2% vs. 31.4%).  
In addition to substance and alcohol dependence, anxiety 
disorder is among the most frequent clinical syndromes, di-
agnosed in 62.7% of participants, higher in women (76.9%) 
than men (59.5%). This data coincides with a study by 
(Ortiz-Tallo, Cardenal, Ferragut and Cerezo, 2011) in the 
clinical population (N = 7011), finding anxiety the most di-
agnosed clinical syndrome, also more common in women 
(53.74% than men (46.26%). There are also significant dif-
ferences in this study in somatoform disorder (15.4% women 
and 0.9% men), dysthymic disorder (46.2% vs.13.8%), post-
traumatic stress disorder (11.5% vs. 1.6%) and finally major 
depression (26.9% vs. 10.3%) in favor of women, while only 
in thought disorder did men (41.4%) present higher rates 
than women (7.7%). It should be noted that despite finding 
no statistically significant differences, narcissistic disorder 





The studies analyzed and the data provided in this research 
indicate high prevalence of psychopathological disorders and 
high comorbidity (dual pathology) in those who have sub-
stance and alcohol abuse. It is also observed that men seek 
most care and treatment, generally exceeding 80% of sam-
ples analyzed, therefore it is essential to analyze the social 
and clinical conditions of women who seek treatment for 
addictive problems.  
Data provided indicate two different impairment paths: 
clinical disorders and personality disorders. The MCMI ques-
tionnaire brings diverse psychopathological and functional 
impairment aspects, and together with the EuropASI, may 
bring a good pre and post evaluation protocol. 
There are several methodological difficulties and limita-
tions that should be taken into account in this study. Firstly, 
the sample comprises people actively seeking treatment for 
addiction, posing a serious difficulty in generalizing this data 
to those who are active substance abusers not seeking treat-
ment. Another limitation is the non-control of variables such 
as relationship of substance of consumption with psycho-
pathological variables, severity of addiction, time of absti-
nence and age, all variables that can mediate results. Our lack 
of control of the history of onset was also important and 
limited our explanations of gathered data. This work has tak-
en gender differences into account; however women only 
comprise 18.31% of the sample. Data obtained from this 
subgroup can provide relevant information toward improv-
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